Compare Neurocrine Biosciences Inc (NBIX) vs NetApp Inc. (NTAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs NetApp Inc. — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while NetApp Inc. trades at $166.94 (market cap $31.57B). The key difference: NetApp Inc. is the larger of the two by market cap, and NetApp Inc. pays a 1.29% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | NTAP | |
|---|---|---|
Market Cap | $17.40B | $31.57B |
Sector | Health | Technology |
52-Week High | $180.55 | $181.08 |
52-Week Low | $123.10 | $94.11 |
Enterprise Value | $16.49B | $30.72B |
Dividend Yield | — | 1.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →
